Home » Authors » Donna Young

Articles by Donna Young

NewCo News: BioVascular, Revitus Merge To Tackle Vascular Problems

Sep. 11, 2007

NewCo News: BioVascular, Revitus Merge To Tackle Vascular Problems

Sep. 11, 2007

FDA Panel to Evaluate Anemia Drug Dosing

Sep. 10, 2007

FDA Panel to Evaluate Anemia Drug Dosing

Sep. 10, 2007

Waxman Says Any Biosimilar Pathway 'Must Be Rigorous'

Sep. 7, 2007

Waxman Says Any Biosimilar Pathway 'Must Be Rigorous'

Sep. 7, 2007

BDSI, Meda Partner On $90M+ Licensing Deal For Opioid Disc

Sep. 6, 2007

BioDelivery Sciences International Inc. is set to receive $30 million in an up-front payment from Swedish specialty pharma Meda AB under a licensing agreement for BEMA Fentanyl, a dissolvable opioid disc product. (BioWorld Today)

BDSI, Meda Partner On $90M+ Licensing Deal For Opioid Disc

Sep. 6, 2007

BioDelivery Sciences International Inc. is set to receive $30 million in an up-front payment from Swedish specialty pharma Meda AB under a licensing agreement for BEMA Fentanyl, a dissolvable opioid disc product. (BioWorld Today)

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Sep. 5, 2007

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Sep. 5, 2007

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...